Cargando…

Autophagy as a target for cancer therapy: new developments

Autophagy is an evolutionarily conserved lysosomal degradation pathway that eliminates cytosolic proteins, macromolecules, organelles, and protein aggregates. Activation of autophagy may function as a tumor suppressor by degrading defective organelles and other cellular components. However, this pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carew, Jennifer S, Kelly, Kevin R, Nawrocki, Steffan T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474143/ https://www.ncbi.nlm.nih.gov/pubmed/23091399 http://dx.doi.org/10.2147/CMAR.S26133

Ejemplares similares

Therapeutic Targeting of Autophagy for Renal Cell Carcinoma Therapy
por: Jones, Trace M., et al.
Publicado: (2020)

Autophagy: New Insights into Its Roles in Cancer Progression and Drug Resistance
por: Nawrocki, Steffan T., et al.
Publicado: (2020)

Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance
por: Carew, Jennifer S, et al.
Publicado: (2008)

Oncolytic Viruses for Multiple Myeloma Therapy
por: Calton, Christine M., et al.
Publicado: (2018)

Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies
por: Jones, Trace M., et al.
Publicado: (2019)

Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer
por: Jones, Trace M., et al.
Publicado: (2021)

Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma
por: Islam, Shariful, et al.
Publicado: (2021)

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus
por: Kelly, Kevin R., et al.
Publicado: (2015)

Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy
por: Kelly, Kevin R., et al.
Publicado: (2017)

Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity
por: Jones, Trace M., et al.
Publicado: (2023)

Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation
por: Carew, Jennifer S, et al.
Publicado: (2010)

Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms
por: Visconte, Valeria, et al.
Publicado: (2016)

The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib
por: Kelly, Kevin R, et al.
Publicado: (2011)

Targeting HSP90 for cancer therapy
por: Mahalingam, D, et al.
Publicado: (2009)

Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism
por: Jones, Trace M., et al.
Publicado: (2022)

Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas
por: Carew, Jennifer S., et al.
Publicado: (2017)

Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models
por: Mahalingam, Devalingam, et al.
Publicado: (2019)

Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer
por: Patel, Sukeshi, et al.
Publicado: (2016)

Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer
por: Carew, J S, et al.
Publicado: (2013)

The role of autophagy in tumour development and cancer therapy
por: Rosenfeldt, Mathias T., et al.
Publicado: (2009)

ELR510444 Inhibits Tumor Growth and Angiogenesis by Abrogating HIF Activity and Disrupting Microtubules in Renal Cell Carcinoma
por: Carew, Jennifer S., et al.
Publicado: (2012)

Comprehensive quantitative proteomic profiling of the pharmacodynamic changes induced by MLN4924 in acute myeloid leukemia cells establishes rationale for its combination with azacitidine
por: Visconte, Valeria, et al.
Publicado: (2015)

Plinabulin, an inhibitor of tubulin polymerization, targets KRAS signaling through disruption of endosomal recycling
por: Cimino, Patrick J., et al.
Publicado: (2019)

ABCG2 Overexpression Contributes to Pevonedistat Resistance
por: Kathawala, Rishil J., et al.
Publicado: (2020)

Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy
por: Liu, Dan, et al.
Publicado: (2023)

Ras and autophagy in cancer development and therapy
por: Schmukler, Eran, et al.
Publicado: (2014)

The Dual Role of Autophagy in Cancer Development and a Therapeutic Strategy for Cancer by Targeting Autophagy
por: Yun, Chul Won, et al.
Publicado: (2020)

AKT as a therapeutic target for autophagy induction and cancer therapy
por: Wu, Qi, et al.
Publicado: (2021)

Targeting autophagy in cancer management – strategies and developments
por: Ozpolat, Bulent, et al.
Publicado: (2015)

Editorial: Targeting autophagy in Cancer Therapy: Focus on small-molecule modulators and new strategies
por: Pluta, Ryszard
Publicado: (2023)

Enhancing Anti-Cancer Therapy with Selective Autophagy Inhibitors by Targeting Protective Autophagy
por: Lee, Min Ju, et al.
Publicado: (2023)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao, Yuqing, et al.
Publicado: (2016)

Hypoxia and Selective Autophagy in Cancer Development and Therapy
por: Daskalaki, Ioanna, et al.
Publicado: (2018)

Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer
por: Eritja, Núria, et al.
Publicado: (2017)

Q&A: targeting autophagy in cancer—a new therapeutic?
por: White, Eileen
Publicado: (2014)

Cooperation of cell adhesion and autophagy in the brain: Functional roles in development and neurodegenerative disease
por: Hernandez, Sarah J., et al.
Publicado: (2021)

Autophagy in preeclampsia: A new target?
por: Cornelius, Denise C., et al.
Publicado: (2020)

Targeting Autophagy for Developing New Therapeutic Strategy in Intervertebral Disc Degeneration
por: Bahar, Md Entaz, et al.
Publicado: (2022)

Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma
por: Mahalingam, D, et al.
Publicado: (2011)

Autophagy as a new therapeutic target in Duchenne muscular dystrophy
por: De Palma, C, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_24l3to3kagndecl2e47ptcbrin